Hologic, Inc.

NasdaqGS:HOLX Rapporto sulle azioni

Cap. di mercato: US$18.3b

Hologic Gestione

Gestione criteri di controllo 4/4

Hologic Il CEO è Steve MacMillan, nominato in Dec2013, e ha un mandato di 10.92 anni. la retribuzione annua totale è $ 15.56M, composta da 7.6% di stipendio e 92.4% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 1.03% delle azioni della società, per un valore di $ 187.69M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.8 anni e 7.9 anni.

Informazioni chiave

Steve MacMillan

Amministratore delegato

US$15.6m

Compenso totale

Percentuale dello stipendio del CEO7.6%
Mandato del CEO10.9yrs
Proprietà del CEO1.0%
Durata media del management3.8yrs
Durata media del Consiglio di amministrazione7.9yrs

Aggiornamenti recenti sulla gestione

Recent updates

When Should You Buy Hologic, Inc. (NASDAQ:HOLX)?

Nov 02
When Should You Buy Hologic, Inc. (NASDAQ:HOLX)?

Hologic: Continued Room Amidst Bolt-On M&A Efforts

Oct 28

Hologic (NASDAQ:HOLX) Seems To Use Debt Rather Sparingly

Oct 17
Hologic (NASDAQ:HOLX) Seems To Use Debt Rather Sparingly

Hologic (NASDAQ:HOLX) Has More To Do To Multiply In Value Going Forward

Sep 16
Hologic (NASDAQ:HOLX) Has More To Do To Multiply In Value Going Forward

Hologic, Inc. (NASDAQ:HOLX) Not Flying Under The Radar

Sep 01
Hologic, Inc. (NASDAQ:HOLX) Not Flying Under The Radar

Hologic Has A Lot Of Fine Qualities, But A Discount Valuation Isn't Among Them

Aug 27

Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)?

Jul 21
Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)?

These 4 Measures Indicate That Hologic (NASDAQ:HOLX) Is Using Debt Reasonably Well

Jun 20
These 4 Measures Indicate That Hologic (NASDAQ:HOLX) Is Using Debt Reasonably Well

Returns At Hologic (NASDAQ:HOLX) Appear To Be Weighed Down

May 22
Returns At Hologic (NASDAQ:HOLX) Appear To Be Weighed Down

Hologic: Women's Health Play Looks Healthier Itself

May 13

Getting In Cheap On Hologic, Inc. (NASDAQ:HOLX) Might Be Difficult

Apr 19
Getting In Cheap On Hologic, Inc. (NASDAQ:HOLX) Might Be Difficult

Calculating The Intrinsic Value Of Hologic, Inc. (NASDAQ:HOLX)

Apr 05
Calculating The Intrinsic Value Of Hologic, Inc. (NASDAQ:HOLX)

Hologic (NASDAQ:HOLX) Has A Pretty Healthy Balance Sheet

Mar 20
Hologic (NASDAQ:HOLX) Has A Pretty Healthy Balance Sheet

Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Feb 22
Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Hologic: Prospects For Growth As Headwinds Disappear

Feb 11

We Think You Can Look Beyond Hologic's (NASDAQ:HOLX) Lackluster Earnings

Feb 09
We Think You Can Look Beyond Hologic's (NASDAQ:HOLX) Lackluster Earnings

Hologic, Inc. Just Beat EPS By 32%: Here's What Analysts Think Will Happen Next

Feb 06
Hologic, Inc. Just Beat EPS By 32%: Here's What Analysts Think Will Happen Next

We Like These Underlying Return On Capital Trends At Hologic (NASDAQ:HOLX)

Jan 29
We Like These Underlying Return On Capital Trends At Hologic (NASDAQ:HOLX)

The Price Is Right For Hologic, Inc. (NASDAQ:HOLX)

Dec 30
The Price Is Right For Hologic, Inc. (NASDAQ:HOLX)

Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 25%?

Dec 11
Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 25%?

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Nov 08
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Should You Think About Buying Hologic, Inc. (NASDAQ:HOLX) Now?

Oct 25
Should You Think About Buying Hologic, Inc. (NASDAQ:HOLX) Now?

Slowing Rates Of Return At Hologic (NASDAQ:HOLX) Leave Little Room For Excitement

Sep 28
Slowing Rates Of Return At Hologic (NASDAQ:HOLX) Leave Little Room For Excitement

Hologic, Inc.'s (NASDAQ:HOLX) Intrinsic Value Is Potentially 35% Above Its Share Price

Aug 29
Hologic, Inc.'s (NASDAQ:HOLX) Intrinsic Value Is Potentially 35% Above Its Share Price

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Jul 31
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Jul 18
Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Return Trends At Hologic (NASDAQ:HOLX) Aren't Appealing

Jun 21
Return Trends At Hologic (NASDAQ:HOLX) Aren't Appealing

Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

May 22
Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Apr 25
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate?

Apr 10
What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate?

Hologic's (NASDAQ:HOLX) Returns On Capital Are Heading Higher

Mar 13
Hologic's (NASDAQ:HOLX) Returns On Capital Are Heading Higher

Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

Feb 14
Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Jan 18
Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Steve MacMillan rispetto agli utili di Hologic?
DataCompenso totaleStipendioGuadagni aziendali
Jun 29 2024n/an/a

US$702m

Mar 30 2024n/an/a

US$467m

Dec 30 2023n/an/a

US$515m

Sep 30 2023US$16mUS$1m

US$456m

Jul 01 2023n/an/a

US$484m

Apr 01 2023n/an/a

US$753m

Dec 31 2022n/an/a

US$990m

Sep 24 2022US$14mUS$1m

US$1b

Jun 25 2022n/an/a

US$2b

Mar 26 2022n/an/a

US$2b

Dec 25 2021n/an/a

US$2b

Sep 25 2021US$15mUS$1m

US$2b

Jun 26 2021n/an/a

US$2b

Mar 27 2021n/an/a

US$2b

Dec 26 2020n/an/a

US$1b

Sep 26 2020US$14mUS$1m

US$1b

Jun 27 2020n/an/a

US$497m

Mar 28 2020n/an/a

US$453m

Dec 28 2019n/an/a

US$84m

Sep 28 2019US$12mUS$1m

-US$204m

Jun 29 2019n/an/a

-US$30m

Mar 30 2019n/an/a

-US$11m

Dec 29 2018n/an/a

-US$419m

Sep 29 2018US$42mUS$1m

-US$111m

Compensazione vs Mercato: La retribuzione totale di Steve ($USD 15.56M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 12.74M ).

Compensazione vs guadagni: La retribuzione di Steve è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Steve MacMillan (60 yo)

10.9yrs

Mandato

US$15,555,032

Compensazione

Mr. Stephen P. MacMillan, also known as Steve, serves as an Independent Chairman of the Board at Illumina, Inc. from June 02, 2023. He has been the Chairman of the Board at Hologic Inc. since June 17, 2015...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Stephen MacMillan
Chairman10.9yrsUS$15.56m1.03%
$ 187.7m
Karleen Oberton
Chief Financial Officer6.3yrsUS$3.93m0.045%
$ 8.1m
Essex Mitchell
Chief Operating Officerless than a yearUS$2.17m0.013%
$ 2.5m
John Griffin
General Counsel9.8yrsUS$3.34m0.079%
$ 14.4m
Jan Verstreken
Group President of Internationalno dataUS$3.52m0.045%
$ 8.2m
Paul Malenchini
Chief Information Officer3.3yrsNessun datoNessun dato
Ryan Simon
Vice President of Investor Relationsno dataNessun datoNessun dato
Diana De Walt
Senior Vice President of Global Human Resourcesless than a yearNessun datoNessun dato
Monica Berthelot
VP & Chief of Staff10.8yrsNessun datoNessun dato
Erik Anderson
Division President of Breast & Skeletal Health Solutions4.3yrsNessun dato0.010%
$ 1.9m
Jennifer Schneiders
President of Diagnostics Solutions1.6yrsNessun dato0.0054%
$ 991.3k
Scott Christensen
Senior Vice President of Global Supply Chain1.1yrsNessun datoNessun dato

3.8yrs

Durata media

56yo

Età media

Gestione esperta: Il team dirigenziale di HOLX è considerato esperto (durata media dell'incarico 3.8 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Stephen MacMillan
Chairman10.9yrsUS$15.56m1.03%
$ 187.7m
Scott Garrett
Independent Director11.5yrsUS$339.96k0.018%
$ 3.3m
Sally Crawford
Independent Director17.1yrsUS$374.96k0.057%
$ 10.3m
Stacey Stewart
Independent Director1.8yrsUS$338.44k0.000070%
$ 12.8k
Ludwig Hantson
Independent Director6yrsUS$319.96k0.0025%
$ 458.2k
Charles Dockendorff
Independent Director7.5yrsUS$344.96k0.0066%
$ 1.2m
Christiana Stamoulis
Independent Director13yrsUS$319.96k0.019%
$ 3.5m
Amy Wendell
Lead Independent Director7.9yrsUS$319.96k0.0076%
$ 1.4m
Nanaz Mohtashami
Independent Director1.2yrsUS$128.96k0.00032%
$ 58.4k

7.9yrs

Durata media

61yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di HOLX sono considerati esperti (durata media dell'incarico 7.9 anni).